Vishweshwar Bhat begins new innings as Editor of Kannada Prabha

[email protected] (News Network)
February 8, 2011

bhat

Mangalore, February 8: Vishweshwar Bhat, the former editor of the 'Vijaya Karnataka', a Kannada daily belonging to The Times of India group, has joined the State's fourth largest news paper, Kannada Prabha, as editor-in-chief.


Manoj Kumar Sonthalia, Chairman and Managing director of The New Indian Express group which owns Kannada Prabha introduced Mr Bhat to the editorial staff and management team of Kannada Prabha at its head office in Bangalore on Monday evening.


On his blog, Mr Bhat called the shift to Kannada Prabha a “homecoming”, having served it for four years as sub-editor in the initial stages of his career and then having done another four year stint at the Asian Schoool of Journalism when it was launched by the Express group.


Along with Mr Bhat, Prathapa Simha, former Chief Sub Editor of VK, P Thyagraj, former Chief Correspondent of VK and Radhakrishna Badthi, former Editor of Lavalavike, a magazine of VK, also set to entre the Kannada Prabha, inside source of the daily said. The trio had quit VK along with guru Mr Bhat.

When Mr Bhat resigned VK nearly two months ago, he had cited pursuing higher studies as the reason for quitting and had subsequently launched his own blog.


Comments

Nagaraj
 - 
Sunday, 1 Jul 2018

Nanna nechhina lekhakaru 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 27,2020

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 7,2020

New Delhi, Jul 7: Congress leader Dinesh Gundu Rao's wife Tabu Gundu Rao informed that four of their employees have tested positive for coronavirus.

"Well sadly our PA, one more Gunman and 2 house staff tested positive. We are all thankfully negative but in isolation and quarantine for 10 to 14 days from today, to check if we develop symptoms as we are primary contacts to them. Hopefully we should get through this," Tabu tweeted.

According to the Ministry of Health and Family Welfare, there are 23,474 coronavirus cases in Karnataka including 13,255 and 372 deaths.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 18,2020

Bengaluru, Feb 18: Passengers of the Ahmedabad bound GoAir flight had a providential escape when the engine of the aircraft while on the roll of take-off hit by a foreign object at the Kempe Gowda Bengaluru International Airport on Tuesday.

'The right engine of GoAir flight G8 802 from Ahmedabad to Bengaluru is suspected to have suffered from foreign object damage (FOD) while on take-off roll,' an official statement said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.